Bayer pulls controversial birth control off market after years of complaints

Adjust Comment Print

Bayer denies that Essure is unsafe or ineffective, and in Friday's statement said that women now using the product can "confidently" rely on it.

Essure, approved by the Food and Drug Administration (FDA) in 2002, is a permanently implanted contraceptive device that does not require a surgical incision. It consists of two-inch long coils that are implanted in the fallopian tubes during a minimally invasive procedure. We expect Bayer to meet its postmarket obligations concerning this device.

Bayer announced Friday it would stop selling a controversial birth control implant after years of lawsuits from thousands of women alleging it caused injury and health issues. At the time of the approval, Essure was manufactured and marketed by Conceptus, Incorporated, a company Bayer acquired in June 2013.

February 2018: FDA officials met with women implanted with Essure and patient advocates to listen to their concerns and experiences with the device.

The Trump Presidency: NYT: Trump recorded discussing secret payment
So that means the only people that would've had access to this thing at Michael Cohen's lawyers and President Trump's lawyers. But Jones pushed back on the designation of 1,452 of those items, so those will be handed over to government investigators.

3 days to Pakistan elections, bomb kills PTI politician
Video images from the scene showed three bleeding and unconscious passengers inside a badly damaged black sports utility vehicle. In 2013, Gandapur's brother Israrullah, who was then the provincial law minister, was killed in an attack on his home.

Secret FBI documents say former Trump adviser was 'collaborating' with Russian Federation
The non-redacted portions of the 400-page FISA document make serious claims about Page's ties to the Russian government. Here's how Trump backtracked last week on earlier skepticism that Russian Federation interfered in the US election.

Bayer spokesman Steven Immergut said the company had sold roughly one million Essure devices worldwide since the product came on the market in 2002.

"The benefit-risk profile of Essure has not changed, and we continue to stand behind the product's safety and efficacy, which are demonstrated by an extensive body of research", Bayer said. Based on that investigation, the FDA issued a black-box warning-the agency's most serious kind of warning-and ordered Bayer to conduct a post-market study to evaluate the safety of Essure. In a statement released by the Agency, FDA Commissioner Scott Gottlieb, MD, said "I want to stress that, even when Essure is no longer sold, the FDA will remain vigilant in protecting patients who've already had this device implanted".

The Food and Drug Administration said earlier this year that over a 15-year period - November 2, 2002, when Essure was approved, through December 2017 - the agency received more than 26,000 reports of problems, including pain, heavier periods and irregular bleeding, headaches and fatigue. We'll continue to monitor adverse events reported to our database, as well as other data sources. They also claim that the device failed to prevent unwanted pregnancies and led to nickel allergies and depression. Our Medical Device Safety Action Plan, issued in April, captures numerous efforts that we're undertaking.

On Tuesday, Firmalino and other Essure activists held a daylong protest outside Bayer's us headquarters in Whippany, N.J. As part of it, they broadcast a clip from the forthcoming Netflix documentary about medical device failures called The Bleeding Edge.